Leptospirosis Pathophysiology: From Entry to Multi-Organ Failure
Leptospirosis, caused by pathogenic Leptospira spirochetes, follows a biphasic course driven by direct bacterial invasion and subsequent immune-mediated injury.
Phase 1: Leptospiremic (Septicemic) Phase — Days 1–7
- Entry: Abraded skin, intact mucous membranes, conjunctiva; water/soil contaminated with reservoir host urine (rodents, livestock).
- Dissemination: Hematogenous spread → endothelial adhesion (adhesins: LipL32, Len proteins) → tissue invasion (liver, kidney, lung, CNS, muscle).
- Direct Effects: Endothelial injury → ↑ capillary permeability → vasculitis, hemorrhage; direct cytotoxicity.
- Clinical: Abrupt fever, rigors, myalgia (calves/lumbar), conjunctival suffusion (pathognomonic), headache, non-productive cough.
Phase 2: Immune Phase — Week 2 Onward
- Antibody Production: IgM (detectable day 5–7), IgG. Immune complex formation.
- Immune-Mediated Injury: Complement activation, neutrophil infiltration, cytokine storm (TNF-α, IL-6, IL-1) → tissue damage exceeding direct bacterial effect.
- Organ-Specific Manifestations:
- Liver: Jaundice (bilirubin ↑↑, transaminases modestly ↑) — Weil's disease.
- Kidney: Tubulointerstitial nephritis → AKI, proteinuria, hypokalemia, non-oliguric initially.
- Lung: Alveolar hemorrhage (diffuse alveolar hemorrhage syndrome) — major cause of death.
- CNS: Aseptic meningitis, encephalitis, cranial nerve palsies.
- Heart: Myocarditis, conduction abnormalities.
- Hemorrhagic Diathesis: Thrombocytopenia, coagulopathy, capillary leak → petechiae, GI bleed, pulmonary hemorrhage.
Severe Disease Predictors
- Age >60, altered mental status, oliguria, pulmonary involvement, thrombocytopenia <70k, bilirubin >5 mg/dL.
Treatment
- Early (≤Day 5): IV Penicillin G / Ceftriaxone / Doxycycline — reduces bacterial load, may abort severe phase.
- Late (Immune Phase): Antibiotics less effective; supportive care (renal replacement, ventilation, transfusion) dominates.
- Corticosteroids: Controversial; some evidence for severe pulmonary hemorrhage.
Early recognition in endemic/exposure settings is critical—treatment delay drives mortality.
Cardiovascular Disease - Related Articles
- Phlebotomy & EKGs: Understanding Common Diagnostic Procedures
- Everflo Oxygen Concentrator: User Guide & Key Features
- Cardiac Asthma: Understanding Causes, Symptoms & Treatment
- Non-Invasive Tests for Coronary Artery Disease (CAD)
- How Weight Gain Impacts Heart Rate & Cardiovascular Health
- Sotalol: Understanding Treatment for Irregular Heartbeat | [Your Brand/Site Name]
- Magnesium Oxide for POTS: Benefits & Side Effects
